Assessment of Transcranial Alternating Current Stimulation's Clinical Efficacy in Treating Cognitive Impairment of Idiopathic Inflammatory Demyelinating Diseases
Diagnosis: Patients with neuromyelitis optica spectrum disease, multiple sclerosis and other inflammatory demyelinating diseases of the central nervous system that meet the diagnostic criteria.
Medications have been stable for at least three months.
You may not be if
Recurrence has been recorded in the past 3 months.
Have a pacemaker or other metal implant in the body.
Impaired skin integrity at the site of electrode placement.
Previous organic brain disease such as epilepsy, hydrocephalus, central nervous system tumors, brain injury, or intracranial infection.
Combined with severe or unstable organic diseases, such as heart, liver and kidney and other organ dysfunction.
Pregnant or lactating women, those who are planning to become pregnant in the near future.
Patient compliance is poor.
In the opinion of the investigator, there is a situation that is not suitable to participate in this study.
Clareo Health | Assessment of Transcranial Alternating Current Stimulation's Clinical Efficacy in Treating Cognitive Impairment of Idiopathic Inflammatory Demyelinating Diseases
